- Home
- TYRA vs MOFG Comparison
TYRA vs MOFG Comparison
Compare TYRA & MOFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYRA
- MOFG
- Stock Information
- Founded
- TYRA 2018
- MOFG 1934
- Country
- TYRA United States
- MOFG United States
- Employees
- TYRA N/A
- MOFG N/A
- Industry
- TYRA Biotechnology: Pharmaceutical Preparations
- MOFG Major Banks
- Sector
- TYRA Health Care
- MOFG Finance
- Exchange
- TYRA Nasdaq
- MOFG Nasdaq
- Market Cap
- TYRA 667.3M
- MOFG 628.8M
- IPO Year
- TYRA 2021
- MOFG N/A
- Fundamental
- Price
- TYRA $12.11
- MOFG $28.88
- Analyst Decision
- TYRA Strong Buy
- MOFG Buy
- Analyst Count
- TYRA 8
- MOFG 2
- Target Price
- TYRA $31.00
- MOFG $34.50
- AVG Volume (30 Days)
- TYRA 243.4K
- MOFG 104.5K
- Earning Date
- TYRA 11-06-2025
- MOFG 10-23-2025
- Dividend Yield
- TYRA N/A
- MOFG 3.32%
- EPS Growth
- TYRA N/A
- MOFG N/A
- EPS
- TYRA N/A
- MOFG N/A
- Revenue
- TYRA N/A
- MOFG $68,312,000.00
- Revenue This Year
- TYRA N/A
- MOFG $240.70
- Revenue Next Year
- TYRA N/A
- MOFG $6.51
- P/E Ratio
- TYRA N/A
- MOFG N/A
- Revenue Growth
- TYRA N/A
- MOFG N/A
- 52 Week Low
- TYRA $6.42
- MOFG $24.62
- 52 Week High
- TYRA $29.60
- MOFG $34.56
- Technical
- Relative Strength Index (RSI)
- TYRA 54.50
- MOFG 44.62
- Support Level
- TYRA $11.70
- MOFG $28.72
- Resistance Level
- TYRA $12.91
- MOFG $30.58
- Average True Range (ATR)
- TYRA 0.67
- MOFG 0.78
- MACD
- TYRA -0.04
- MOFG -0.14
- Stochastic Oscillator
- TYRA 30.38
- MOFG 6.07
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
About MOFG MidWestOne Financial Gp
MidWestOne Financial Group Inc is a bank holding company engaged in delivering relationship-based business and personal banking products and services. The Bank provides commercial loans, real estate loans, agricultural loans, credit card loans, and consumer loans. It also provides deposit products including demand and interest checking accounts, savings accounts, money market accounts, and time deposits. The Bank also provides products and services including treasury management, Zelle, online and mobile banking, debit cards, ATMs, and safe deposit boxes. The Bank offers its products and services through its network of full-service banking offices. the Bank's investments services department offers financial planning, investment advisory, and retail securities brokerage services.